http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013203489-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00
filingDate 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c281f415e8eca6ccd916d8a7744d004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46c5c6a1b66f4232e0de85dbf1dff1a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b23bdd5c271354396af2f0efcf6b7604
publicationDate 2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2013203489-B2
titleOfInvention Once-a-week administration of 25-hydroxy vitamin D3 to sustain elevated steady-state pharmacokinetic blood concentration
abstract A composition for oral or parenteral administration comprising a single dose of 25-hydroxy-vitamin D3 sufficient to elevate the serum level in a human to a concentration in the range of 30 ng/ml to 200 ng/ml for at least 7 days and a pharmaceutically suitable carrier system, wherein subsequent single doses at least every 7 days are sufficient to sustain the serum level in a human to a concentration in the range of 30 ng/ml to 200 ng/ml at steady-state pharmacokinetics is disclosed. A method of elevating and sustaining the blood level concentration of 25-hydroxy-vitamin D3 in a human in need thereof comprising said orally administering or parenterally administering composition is also disclosed. The human in need thereof may be a human deficient in vitamin D having a serum level concentration of 25-hydroxy-vitamin D3 less than 30 ng/ml. WO 2010/011906 PCTIUS2009/051664 cc ng/mI CD<IiD C) C) C) .-. CD CD CD c cD C) . . . . . . . oo
priorityDate 2008-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID270461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426092009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426259740
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID8030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5710148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422707967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25127095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24779641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590896
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18326
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID270461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9547243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134070
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID8030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426078917

Total number of triples: 38.